Waste from pharmaceutical plants in India and China promotes antibiotic-resistant superbugs
(By Henry A. Waxman and Bill Corr for STAT) Superbugs, disease-causing microbes that have mutated to become resistant to antibiotics,
Read More
Part D/Prescription Drugs
The insulin market is heading for a shakeup. But patients may not benefit
(By Rebecca Robbins for STAT) The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of
Read MoreWhy Is The News About TB So Bad?
(By Rina Shalkh-Lasko for NPR) Many countries think of TB as a disease of the past and this lack of
Read MoreOpen Enrollment–Time to Re-Check Your Drug Coverage
The annual Medicare Open Enrollment period, which runs through December 7, provides an opportunity to re-examine your Part D drug
Read MoreOpen Enrollment–Some Specific Potential Cost-Savers to Look At
Medicare expert Philip Moeller, in a post today on philly.com, provides a synopsis of several key areas where Medicare participants
Read MoreMedicare Advantage Examined as Open Enrollment Kicks Off
Todd Campbell of Motley Fool takes a look at the changes in store for Medicare Advantage participants in 2017 in
Read MoreA big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it
(By Damian Garde for STAT) Scientists at Eli Lilly are racing to wrap up a clinical trial on a drug
Read MoreOut-of-pocket burden for breast cancer treatment varies across US
(By Kelly Gooch for Becker’s Hospital Review) Breast cancer chemotherapy costs vary widely across the United States, with patients taking
Read MoreDEA opts against ban on herbal supplement kratom
(By Alicia A. Cardwell of Associated Press for STAT) WASHINGTON — The Drug Enforcement Administration has reversed a plan to temporarily
Read MoreSenator demands federal agencies limit use of prescription fentanyl
(By David Armstrong for STAT) A US senator is urging federal agencies to limit the use of a prescription version
Read More